Robert D. Hardie, 10% Owner at Acumen Pharmaceuticals, Inc. (ABOS), bought 3,262,984 shares at $16.00 ($5.0M) on 2021-07-06, disclosed to the SEC on 2021-07-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,950,484 | $0 | 0.0% |
| 2 | $16.00 | 312,500 | $5.0M | 100.0% |
| Total | $1.53 avg | 3,262,984 | $5.0M | 100% |